Compare StocksUNH vs VTR

UnitedHealth Group Incorporated (UNH) vs Ventas, Inc. (VTR): Which Is the Better Buy in 2026?

As of 2026-06-19, UNH is fairly valued at $401, with a DCF intrinsic value of $376 and a margin of safety of -7%. VTR is undervalued at $82, with an intrinsic value of $206 and a margin of safety of 60%. Of the two, VTR has the wider margin of safety.

UNH
UnitedHealth Group Incorporated
$400.96
VS
VTR
Ventas, Inc.
$81.60

Rewards

UNH
  • UnitedHealth Group Incorporated scores 73/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
VTR

    Risks

    UNH
    • ROIC has declined by 6.9 percentage points over the past 4 years, which may signal competitive erosion.
    • Gross margin of 18.8% is low, suggesting a competitive or commodity-like market with limited pricing power.
    • Free cash flow has declined at a 11.8% CAGR over the past 4 years — a concerning trend.
    VTR
    • Net debt/EBITDA of 5.5x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.

    Key Valuation Metrics

    Learn more →
    UNH
    VTR
    Valuation
    $17.69B
    Free Cash Flow
    $1.48B
    4.86%
    FCF Yield
    3.74%
    30.17
    Trailing P/E
    148.36
    19.18
    Forward P/E
    96.38
    Quality & Moat
    15.60%
    ROIC
    2.53%
    12.18%
    ROE
    2.14%
    18.80%
    Gross Margin
    40.49%
    1.41
    PEG Ratio
    1.72
    Balance Sheet Safety
    0.44
    Net Debt / Equity
    0.92
    N/A
    Interest Coverage
    N/A
    2.18
    Net Debt / EBITDA
    5.48
    2.21%
    Dividend Yield
    2.38%
    UNH: 9Ties: 1VTR: 2
    UNHVTR

    Historical Fundamentals

    Learn more →
    UNH

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    VTR
    No historical data available.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    UNH
    $-7.37
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $26.63B
    Δ Market Cap
    $-196.16B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    VTR
    Not enough historical data to compute the retained earnings test.

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    UNH
    6.6% Overvalued
    Price is 6.6% above estimated fair value
    Current Price: $400.96
    Fair Value: $376.14
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    VTR
    60.4% Margin of Safety
    Price is 60.4% below estimated fair value
    Current Price: $81.60
    Fair Value: $205.91
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    UNH

    What growth rate is the market pricing in at $401?

    +14.1%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +9.8%

    The market implies +14.1% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +9.8%, reflecting heavy growth investment.

    VTR

    What growth rate is the market pricing in at $82?

    +15.4%
    Market-Implied FCF Growth Rate

    Economic Moat Score

    Learn more →
    UNH
    73/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    VTR

    Insufficient data for Economic Moat Score calculation (requires 3+ years).

    Forensic Accounting

    Learn more →
    UNH
    -2.45
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    VTR

    Insufficient data for Beneish M-Score calculation (requires 2+ years).

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    UNH
    Insiders 0.2%Institutions 85.9%Retail & Other 13.8%
    No. of Institutional Holders4,020
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    VTR
    Insiders 0.5%Institutions 107.0%
    No. of Institutional Holders1,364
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    UNH
    0
    Buys (3M)
    0
    Buys (12M)
    HEMSLEY STEPHEN J
    Chief Executive Officer
    $25.02M
    @ $288.57 · 2025-05-16
    REX JOHN F
    President
    $5.00M
    @ $291.12 · 2025-05-16
    GIL KRISTEN
    Director
    $1.00M
    @ $271.17 · 2025-05-15
    FLYNN TIMOTHY PATRICK
    Director
    $491,786
    @ $320.80 · 2025-05-14
    NOSEWORTHY JOHN H
    Director
    $93,647
    @ $312.16 · 2025-05-14
    FLYNN TIMOTHY PATRICK
    Director
    $511,575
    @ $511.57 · 2025-01-17
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    VTR
    1
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $197,025
    EMBLER MICHAEL J
    Director
    $197,025
    @ $78.81 · 2026-06-03
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    UNH
    1
    Sells (3M)
    1
    Sells (12M)
    Total value (12M): $284,000
    CONWAY PATRICK HUGH M.D.
    Officer
    $284,000
    @ $355.00 · 2026-04-23
    CONWAY PATRICK HUGH M.D.
    Chief Executive Officer
    $179,645
    @ $305.00 · 2025-06-10
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    VTR
    1
    Sells (3M)
    27
    Sells (12M)
    Total value (12M): $77.75M
    RAKOWICH WALTER C.
    Director
    $103,915
    @ $90.20 · 2026-05-14
    ROBERTS CAREY SHEA
    General Counsel
    $3.02M
    @ $85.00 · 2026-02-11
    CAFARO DEBRA A
    Chief Executive Officer
    $848,751
    @ $82.23 · 2026-02-06
    CAFARO DEBRA A
    Chief Executive Officer
    $801,605
    @ $77.66 · 2026-02-02
    PROBST ROBERT F.
    Chief Financial Officer
    $2.31M
    @ $77.25 · 2026-01-02
    CAFARO DEBRA A
    Chief Executive Officer
    $797,475
    @ $77.26 · 2026-01-02
    CAFARO DEBRA A
    Chief Executive Officer
    $831,419
    @ $80.55 · 2025-12-01
    BULGARELLI PETER J
    Officer
    $400,205
    @ $80.04 · 2025-11-19
    CAFARO DEBRA A
    Chief Executive Officer
    $3.26M
    @ $79.01 · 2025-11-17
    PROBST ROBERT F.
    Chief Financial Officer
    $2.58M
    @ $76.77 · 2025-11-12
    BULGARELLI PETER J
    Officer
    $3,028
    @ $75.70 · 2025-11-07
    BULGARELLI PETER J
    Officer
    $372,256
    @ $75.05 · 2025-11-06
    CAFARO DEBRA A
    Chief Executive Officer
    $2.33M
    @ $75.19 · 2025-11-06
    CAFARO DEBRA A
    Chief Executive Officer
    $25.08M
    @ $74.22 · 2025-11-03
    CAFARO DEBRA A
    Chief Executive Officer
    $15.66M
    @ $71.32 · 2025-10-20
    BULGARELLI PETER J
    Officer
    $322,215
    @ $70.14 · 2025-10-01
    CAFARO DEBRA A
    Chief Executive Officer
    $724,986
    @ $70.24 · 2025-10-01
    BULGARELLI PETER J
    Officer
    $28,419
    @ $70.00 · 2025-09-15
    CAFARO DEBRA A
    Chief Executive Officer
    $699,864
    @ $67.80 · 2025-09-02
    PROBST ROBERT F.
    Chief Financial Officer
    $2.03M
    @ $68.49 · 2025-08-04
    CAFARO DEBRA A
    Chief Executive Officer
    $695,722
    @ $67.40 · 2025-08-01
    PROBST ROBERT F.
    Chief Financial Officer
    $266,960
    @ $68.45 · 2025-07-31
    PROBST ROBERT F.
    Chief Financial Officer
    $1.95M
    @ $66.29 · 2025-07-21
    PROBST ROBERT F.
    Chief Financial Officer
    $271,454
    @ $66.24 · 2025-07-18
    CAFARO DEBRA A
    Chief Executive Officer
    $287,976
    @ $65.82 · 2025-07-18
    CAFARO DEBRA A
    Chief Executive Officer
    $1.07M
    @ $65.60 · 2025-07-16
    PROBST ROBERT F.
    Chief Financial Officer
    $11.00M
    @ $65.36 · 2025-07-14
    ROBERTS CAREY SHEA
    General Counsel
    $1.51M
    @ $64.23 · 2025-05-30
    PROBST ROBERT F.
    Chief Financial Officer
    $1.13M
    @ $65.22 · 2025-05-27
    PROBST ROBERT F.
    Chief Financial Officer
    $4.50M
    @ $64.59 · 2025-05-21
    RAKOWICH WALTER C.
    Director
    $93,026
    @ $63.76 · 2025-05-14
    CAFARO DEBRA A
    Chief Executive Officer
    $682,135
    @ $66.09 · 2025-05-02
    CAFARO DEBRA A
    Chief Executive Officer
    $3.17M
    @ $71.06 · 2025-04-03
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    UNH
    FearGreed
    😏Greed(68/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    VTR
    FearGreed
    😐Neutral(53/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    UNH
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (68)
    VTR
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (53)
    View UNH Full AnalysisView VTR Full Analysis

    Frequently Asked Questions: UNH vs VTR

    Is UnitedHealth Group Incorporated or Ventas, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, VTR trades at a 60.4% margin of safety (intrinsic value $206 vs. price $82), compared to UNH's -6.6% margin of safety (intrinsic $376 vs. $401).

    Which company has better free cash flow, UnitedHealth Group Incorporated or Ventas, Inc.?

    UnitedHealth Group Incorporated (UNH) generates a 4.9% free cash flow yield, compared to Ventas, Inc.'s 3.7%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, UnitedHealth Group Incorporated or Ventas, Inc.?

    UNH earns 15.6% ROIC versus VTR's 2.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.